It’s a great pleasure to welcome you to the 9th Congress on Neurobiology, Psychopharmacology and Treatment Guidance which will be held on March 8th-10th 2024 in Thessaloniki, Greece.
With the COVID-19 pandemic at its end, and with all the devastation and challenges it produced, but with the new challenges imposed by the war and the global recession, we are resuming our efforts with this 9th Congress which again aims at being valuable for the clinicians who fight daily in the front line for the treatment of real-world patients. In this frame, our goal is to provide a global and comprehensive update of the newest developments in Psychiatry and the allied sciences in a manner, which will be both focused and enriched. The rule is always to avoid content-free eloquence and authority and to face hard questions on the base of research findings.
The congress will gather again many worldwide experts to share with us their knowledge and experience once again with the support and guidance of the World Psychiatric Association and under the Auspices of the School of Medicine, Aristotle University of Thessaloniki.
During these difficult circumstances for the world, advanced education and training is the only way to the future. Novel and advanced technologies and approaches are emerging. Teaching clinical usefulness and application of new knowledge and informed treatment with psychopharmacological agents in a truly multidisciplinary approach will be the central axis of the meeting and although the congress will embrace high tech research concerning psychopathology, new treatment methods, genetics and molecular biology, it also aims on putting the emphasis on the human factor, both the therapist and the patient.
Apart from the humanistic tradition of Psychiatry and life sciences, the continuous and unconditional investment on the high level training of professionals and education of patients and their families, emerged as a significant challenge during the last few decades. Medical scientists and public health policy makers are increasingly concerned that the scientific discoveries are failing to be translated efficiently into tangible human benefit. Today, in an all the more complex and technologically advanced environment, the human factor emerges again as the most valuable one, the factor that determines the final outcome.
This 9th ICNP specifically focuses on the ultimate aim: that is to empower and eventually free patients and their families from the burden of mental disease and fighting for full remission and functional rehabilitation. It also includes the distinguished aim to spread high-level training to younger generations by including symposia organized by medical students and psychiatric residents from around the world. As hosts and organizers, we shall spare no effort in making your participation scientifically rewarding and meaningful.
Konstantinos N. Fountoulakis
Professor of Psychiatry, Aristotle University of Thessaloniki, Greece
Chair of the Scientific Faculty
Director, 3rd Department of Psychiatry, Aristotle University of Thessaloniki Greece
Chair, WPA Section on Pharmakopsychiatry and Section on Evidence-Based Psychiatry
DATES & VENUE
March 8th -10th 2024
Porto Palace Hotel, Thessaloniki, Greece
(65, 26th Octovriou Avenue, T. +30 2310 504504, F. +30 2310 540384, firstname.lastname@example.org)
English will be the official language of the Congress. No simultaneous translation will be provided.
Delegates are obliged to show their congress badge at the entrance of Congress Hall for their attendance time to be registered.
CERTIFICATE OF ATTENDANCE
All delegates will receive the certificate of attendance. Certificates will be provided after the completion of the scientific program by email.
Available visual equipment for all presentations will be through power point presentation. Presentations must be submitted to the technical secretariat 1 hour prior to the presentation. The use of personal computers will not be feasible.
Within the congress area there will be an exhibition of pharmaceutical products.
Δείτε περισσότερα στην ιστοσελίδα του Συνεδρίου.